Solid Biosciences Inc (NASDAQ: SLDB) is 50.00% higher on its value in year-to-date trading and has touched a low of $2.88 and a high of $15.05 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The SLDB stock was last observed hovering at around $6.47 in the last trading session, with the day’s loss setting it -0.47%.
Currently trading at $6.00, the stock is 62.80% and 53.10% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.39 million and changing -7.26% at the moment leaves the stock -8.27% off its SMA200. SLDB registered -40.12% loss for a year compared to 6-month loss of -35.34%.
The stock witnessed a 84.05% gain in the last 1 month and extending the period to 3 months gives it a 23.71%, and is 69.97% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 22.48% over the week and 12.48% over the month.
Solid Biosciences Inc (SLDB) has around 88 employees, a market worth around $457.91M and $0.00M in sales. Distance from 52-week low is 108.33% and -60.13% from its 52-week high. The company has generated returns on investments over the last 12 months (-54.21%).
The EPS is expected to grow by 39.19% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
The shares outstanding are 38.93M, and float is at 31.74M with Short Float at 8.35%.
Solid Biosciences Inc (SLDB) Insider Activity
The most recent transaction is an insider purchase by Adage Capital Management, L.P., the company’s 10% Owner. SEC filings show that Adage Capital Management, L.P. bought 252,545 shares of the company’s common stock on Feb 18 ’25 at a price of $7.56 per share for a total of $1.91 million. Following the purchase, the insider now owns 4.25 million shares.
Solid Biosciences Inc disclosed in a document filed with the SEC on Feb 14 ’25 that Hanrahan Jessie (Chief Regulatory Officer) sold a total of 3,079 shares of the company’s common stock. The trade occurred on Feb 14 ’25 and was made at $3.96 per share for $12193.0. Following the transaction, the insider now directly holds 19281.0 shares of the SLDB stock.
Still, SEC filings show that on Feb 14 ’25, Brooks Gabriel (Chief Medical Officer) disposed off 3,256 shares at an average price of $3.96 for $12894.0. The insider now directly holds 22,812 shares of Solid Biosciences Inc (SLDB).
